Compare ENVX & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENVX | ATRC |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2020 | 2005 |
| Metric | ENVX | ATRC |
|---|---|---|
| Price | $8.25 | $27.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $13.61 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 8.4M | 743.9K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 40.94 | ★ 74.74 |
| EPS | N/A | ★ N/A |
| Revenue | $31,821,000.00 | ★ $201,630,000.00 |
| Revenue This Year | $30.37 | $15.27 |
| Revenue Next Year | $238.73 | $12.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 37.91 | 15.40 |
| 52 Week Low | $4.67 | $25.36 |
| 52 Week High | $16.49 | $43.18 |
| Indicator | ENVX | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 65.49 | 46.24 |
| Support Level | $7.25 | $26.47 |
| Resistance Level | $8.79 | $30.49 |
| Average True Range (ATR) | 0.65 | 1.28 |
| MACD | 0.17 | -0.14 |
| Stochastic Oscillator | 78.59 | 44.25 |
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.